2IIV
Human dipeptidyl peptidase 4 in complex with a diazepan-2-one inhibitor
2IIV の概要
| エントリーDOI | 10.2210/pdb2iiv/pdb |
| 関連するPDBエントリー | 2IIT |
| 分子名称 | Dipeptidyl peptidase 4 soluble form, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose, ... (5 entities in total) |
| 機能のキーワード | hydrolase; alpha/beta; beta-propeller; dimer, hydrolase |
| 由来する生物種 | Homo sapiens (human) |
| タンパク質・核酸の鎖数 | 2 |
| 化学式量合計 | 174565.63 |
| 構造登録者 | |
| 主引用文献 | Biftu, T.,Feng, D.,Qian, X.,Liang, G.B.,Kieczykowski, G.,Eiermann, G.,He, H.,Leiting, B.,Lyons, K.,Petrov, A.,Sinha-Roy, R.,Zhang, B.,Scapin, G.,Patel, S.,Gao, Y.D.,Singh, S.,Wu, J.,Zhang, X.,Thornberry, N.A.,Weber, A.E. (3R)-4-[(3R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-(2,2,2-trifluoroethyl)-1,4-diazepan-2-one, a selective dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes Bioorg.Med.Chem.Lett., 17:49-52, 2007 Cited by PubMed Abstract: Replacement of the triazolopiperazine ring of sitagliptin (DPP-4 IC(50)=18nM) with 3-(2,2,2-trifluoroethyl)-1,4-diazepan-2-one gave dipeptidyl peptidase IV (DPP-4) inhibitor 1 which is potent (DPP-4 IC(50)=2.6nM), selective, and efficacious in an oral glucose tolerance test in mice. It was selected for extensive preclinical development as a potential back-up candidate to sitagliptin. PubMed: 17055272DOI: 10.1016/j.bmcl.2006.09.099 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (2.15 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






